Seems $35m new cash is an awful lot when so close to profitability, doesn't it Balance?
Must have an acquisition in mind.
Printable View
They must have a serious push... because it is a fair bit, but potentially required to make a 'big effort'
Looks to me like the $100m in accumulated losses will happen well before the $100m in revenue :)
So where was FED Med-ACPN-Stratose and Multiplan? They have signed up--Are they waiting for the results of KP program?-(and who are they using in the mean time?)-That will be 2016--Edison must have been in discussions to have stated that.
It appears that the trial and hopefully CMS coverage is of crucial importance now--But of course there is as always so much we dont know.
At the moment they appear vulnerable so the capital raising is important and they appear to have ,at least temporarily to have lost investor confidence---And yet they have this great product--They could really do with a ''Xero''type investor partner at this stage.
I didnt want to mention in the heat of the announcement but for a while Ive had my doubts about targeting Urologists instead of doctors for an ''initial'' test--I would have thought that it would be the perfect solution (after blood tests)to rule out an expensive specialist.
Anyway, its more of a ''getting through this'' than ''full steam ahead'' (it seems)
Ill say it for Mac--''Its the Kaiser report and coverage that will bring sales''--Its just to bad its farther off than we thought--(and of course the doubts get harder to dispel as time goes on)
Heap of cash alright.
I'm not sure why they would do an acquisition, they're struggling to sell CxBladder as it is.
With a lot in the "pipeline".
More likely trying to ramp up sales/ realised profitability is a while off and decided to raise cash while there's still some support.
Why all that cash? Apparently so they can start paying dividends. Keep the shareprice up based on 'yield'.
http://www.news-medical.net/news/201...stic-tool.aspx
My apologies if this has already been posted.